Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Novo Nordisk A/S (NVO) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Novo Nordisk A/S (NVO) - free report >>
Image: Shutterstock
Best Momentum Stocks to Buy for June 5th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, June 5th:
Vipshop Holdings Limited (VIPS - Free Report) : This company that operates online platforms for various brands in China has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 17.6% over the last 60 days.
Vipshop Holdings Limited Price and Consensus
Vipshop Holdings Limited price-consensus-chart | Vipshop Holdings Limited Quote
Vipshop’s shares gained 9.7% over the last three months compared with the S&P 500’s advance of 6.7%. The company possesses a Momentum Score of A.
Vipshop Holdings Limited Price
Vipshop Holdings Limited price | Vipshop Holdings Limited Quote
Coca-Cola FEMSA, S.A.B. de C.V. (KOF - Free Report) : This franchise bottling company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.4% over the last 60 days.
Coca Cola Femsa S.A.B. de C.V. Price and Consensus
Coca Cola Femsa S.A.B. de C.V. price-consensus-chart | Coca Cola Femsa S.A.B. de C.V. Quote
Coca-Cola FEMSA’s shares gained 9.7% over the last three months compared with the S&P 500’s advance of 6.7%. The company possesses a Momentum Score of A.
Coca Cola Femsa S.A.B. de C.V. Price
Coca Cola Femsa S.A.B. de C.V. price | Coca Cola Femsa S.A.B. de C.V. Quote
Novo Nordisk A/S (NVO - Free Report) : This pharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.4% over the last 60 days.
Novo Nordisk A/S Price and Consensus
Novo Nordisk A/S price-consensus-chart | Novo Nordisk A/S Quote
Novo’s shares gained 8.5% over the last three months compared with the S&P 500’s advance of 6.7%. The company possesses a Momentum Score of B.
Novo Nordisk A/S Price
Novo Nordisk A/S price | Novo Nordisk A/S Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.